BDMD Valuation
Baird Medical Investment Holdings Ltd
$
2.570
- Overview
- Forecast
- Valuation
- Earnings
BDMD Relative Valuation
BDMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BDMD is overvalued; if below, it's undervalued.
Historical Valuation
Baird Medical Investment Holdings Ltd (BDMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Baird Medical Investment Holdings Ltd (BDMD) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：2.61
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Baird Medical Investment Holdings Ltd. (BDMD) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Baird Medical Investment Holdings Ltd. (BDMD) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Baird Medical Investment Holdings Ltd. (BDMD) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Baird Medical Investment Holdings Ltd. (BDMD) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Baird Medical Investment Holdings Ltd. (BDMD) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Baird Medical Investment Holdings Ltd (BDMD) has a current Price-to-Book (P/B) ratio of 1.68. Compared to its 3-year average P/B ratio of 2.95 , the current P/B ratio is approximately -42.90% higher. Relative to its 5-year average P/B ratio of 2.95, the current P/B ratio is about -42.90% higher. Baird Medical Investment Holdings Ltd (BDMD) has a Forward Free Cash Flow (FCF) yield of approximately -12.84%. Compared to its 3-year average FCF yield of -9.95%, the current FCF yield is approximately 28.98% lower. Relative to its 5-year average FCF yield of -9.95% , the current FCF yield is about 28.98% lower.
1.68
P/B
Median3y
2.95
Median5y
2.95
-12.84
FCF Yield
Median3y
-9.95
Median5y
-9.95
Competitors Valuation Multiple
The average P/S ratio for BDMD's competitors is 0.57, providing a benchmark for relative valuation. Baird Medical Investment Holdings Ltd Corp (BDMD) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BDMD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of BDMD in the past 1 year is driven by Unknown.
People Also Watch
AMRN
Amarin Corporation PLC
14.920
USD
+2.19%
CRD.B
Crawford & Co
10.240
USD
-1.44%
NC
NACCO Industries Inc
43.090
USD
+2.60%
LWLG
Lightwave Logic Inc
3.690
USD
+22.59%
FLYX
Flyexclusive Inc
5.300
USD
-2.21%
FUND
Sprott Focus Trust Inc
8.180
USD
+0.49%
SGMO
Sangamo Therapeutics Inc
0.550
USD
+7.22%
CRDF
Cardiff Oncology Inc
2.160
USD
+7.46%
PLCE
Children's Place Inc
6.940
USD
-8.20%
ABEO
Abeona Therapeutics Inc
5.640
USD
0.00%
FAQ
Is Baird Medical Investment Holdings Ltd (BDMD) currently overvalued or undervalued?
Baird Medical Investment Holdings Ltd (BDMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Baird Medical Investment Holdings Ltd (BDMD) is between to according to relative valuation methord.
What is Baird Medical Investment Holdings Ltd (BDMD) fair value?
How does BDMD's valuation metrics compare to the industry average?
What is the current P/B ratio for Baird Medical Investment Holdings Ltd (BDMD) as of Sep 18 2025?
What is the current FCF Yield for Baird Medical Investment Holdings Ltd (BDMD) as of Sep 18 2025?
What is the current Forward P/E ratio for Baird Medical Investment Holdings Ltd (BDMD) as of Sep 18 2025?